Video

How Has Immunotherapy Evolved in the Advanced NSCLC Setting?

Josh Sabari, MD; Nicholas C. Rohs, MD; and Balazs Halmos, MD, highlight new therapeutic advances in the advanced setting of non–small cell lung cancer unveiled throughout 2021.

Video Player is loading.
Current Time 0:00
Duration 13:08
Loaded: 0%
Stream Type LIVE
Remaining Time 13:08
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected

Josh Sabari, MD; Nicholas C. Rohs, MD; and Balazs Halmos, MD, highlight new therapeutic advances in the advanced setting of non–small cell lung cancer unveiled throughout 2021.

Funding from Daiichi Sankyo/Content Independently Developed by OncLive

Related Content